SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of Bitcoin under its crypto reserve strategy targeting multi-chain asset growth. “Silo’s latest strategic crypto purchase signals our conviction in Bitcoin as both store of value and a hedge against general financial market volatility,” said Eric Weisblum, CEO of Silo. “Overall, ...

SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) --   Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its initial purchase of Bitcoin under its crypto reserve strategy targeting multi-chain asset growth. “Silo’s latest strategic crypto purchase signals our conviction in Bitcoin as both store of value and a hedge against general financial market volatility,” said Eric Weisblum, CEO of Silo. “Overal ...